CTOs on the Move

Outset Medical

www.outsetmedical.com

 
Outset is a pioneering medical technology company that always puts the patient before the machine. Our human-centered model is designed to dramatically improve not only the care experience – for patients, families, providers and physicians alike – but also cost-efficiencies for providers. And to achieve this goal, we brought together the most dedicated, creative minds from dialysis with the most dedicated, creative minds from other healthcare fields, in the belief that cross-fertilization – along with hard work – is the surest path to invention. Because we believe a dialysis machine should be as easy to use as an everyday consumer ...
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Funding

Outset Medical raised $91M on 06/10/2015
Outset Medical raised $132M on 08/28/2018
Outset Medical raised $125M on 02/05/2020
Outset Medical raised $149.7M on 04/13/2021

Similar Companies

PL Developments

PL Developments is a Westbury, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Kensington Green Of Southbury

Kensington Green Of Southbury is a Southbury, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Redox

Healthcare organizations and technology vendors connect to Redox once, then authorize what data they send to and receive from partners through a centralized hub. Redox`s cloud-based platform is vendor and standards agnostic and enables the secure and efficient exchange of healthcare data. This approach eradicates the need for point-to-point integrations and accelerates the discovery, adoption, and distribution of patient and provider-facing technology solutions. With hundreds of healthcare organizations and technology vendors exchanging data today, Redox represents the largest interoperable network in healthcare.

Acucela

Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide. Acucela currently has the following candidates in development with Otsuka Pharmaceutical: emixustat hydrochloride for GA associated with dry AMD based on Acucela’s proprietary visual cycle modulation; and OPA-6566 for ocular hypertension and glaucoma.

Cambridge Healthtech Institute

Cambridge Healthtech Institute is a Needham Heights, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.